iShares Health Innovation Active ETF

BMEDAMEX · USD
36.40USD+0.38 (+1.05%)

iShares Health Innovation Active ETF (BMED) Option Chain

Read more

Tracking the BMED option chain helps you see every strike and expiry on iShares Health Innovation Active ETF in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BMED options activity at a glance. Use our scanner to monitor the BMED option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BMED stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where BMED options are being actively traded, and where they are not.

The iShares Health Innovation Active ETF (the “Fund”) seeks to maximize total return by investing in innovative and emerging companies in the healthcare sector.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
20.9600-0.152.400.603.9034.00-5.61—1.550.001.550079.04
34.61000.481.400.802.9535.00-2.83—1.550.001.550065.39
50.17001.950.40—2.3536.00-0.06—1.700.001.700049.83
65.30001.950.00—1.9537.00+2.72—1.950.601.350034.70
78.00001.700.00—1.7038.00+5.500.452.551.60-0.100021.99

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryExchange Traded Fund
  • SectorFinancial
  • IV Rank96.43% High
  • Market cap (M$)—
  • 52 weeks high-3.43%
  • 52 weeks low32.18%
  • Analyst recommendation—
  • Target price—
  • Dividend—
  • Payout ratio—
  • Earnings date—
  • P/E—
  • Future P/E—
  • EPS (ttm)—
  • EPS growth next 5 years—

As of Nov 5, 2026